Cargando…
A Global Overview of Precision Medicine in Type 2 Diabetes
The detailed characterization of human biology and behaviors is now possible at scale owing to innovations in biomarkers, bioimaging, and wearable technologies; “big data” from electronic medical records, health insurance databases, and other platforms becoming increasingly accessible; and rapidly e...
Autores principales: | Fitipaldi, Hugo, McCarthy, Mark I., Florez, Jose C., Franks, Paul W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152339/ https://www.ncbi.nlm.nih.gov/pubmed/30237159 http://dx.doi.org/10.2337/dbi17-0045 |
Ejemplares similares
-
Learning From Molecular Genetics: Novel Insights Arising From the Definition of Genes for Monogenic and Type 2 Diabetes
por: McCarthy, Mark I., et al.
Publicado: (2008) -
Extending precision medicine tools to populations at high risk of type 2 diabetes
por: Misra, Shivani, et al.
Publicado: (2022) -
Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine
por: Udler, Miriam S, et al.
Publicado: (2019) -
The Streetlight Effect in Type 1 Diabetes
por: Battaglia, Manuela, et al.
Publicado: (2015) -
Hypoglycemia in Type 1 Diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2010)